📰 Code Therapeutics News
Page 4 - Code Therapeutics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Code Therapeutics. Real-time updates on events, politics, business and more.
October 31, 2023
Gainers LumiraDx Limited (NASDAQ: LMDX) shares surged 38.8% to $0.1250 in pre-market trading. LumiraDX shares fell 25% on Monday after the company announced the receipt of the Nasdaq delisting determination.
October 31, 2023
Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 80% to $6.14 after the company announced it received notice of acceptance from the Australian patent office for its patent application for Combination of Opioids and N-Acylethanolamines for pain treatment.
October 30, 2023
Gabby Everett, the site director for BioLabs Pegasus Park, offered a tour of the space and shared some examples of why early-stage life science companies should choose North Texas.
October 27, 2023
BOSTON, Oct. 27, 2023 (GLOBE NEWSWIRE) -- TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an RNA oncology company committed to more...
October 27, 2023
InvestorPlace - Stock Market News, Stock Advice & Trading Tips TransCode Therapeutics stock is falling on Friday after the company announced plans for a…
October 27, 2023
U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining more than 100 points on Friday. Following the market opening Friday, the Dow traded down 0.12% to 32,744.42 while the NASDAQ rose 0.82% to 12,699.50. The S&P 500 also rose, gaining, 0.24% to 4,147.09.
October 27, 2023
Gainers Apollomics, Inc. (NASDAQ: APLM) shares surged 88.4% to $1.07 stoma multiforme with PTPRZ-MET fusion.
September 28, 2023
TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 126,400 shares, an increase of 418.0% from the August 31st total of 24,400 shares. Approximately 7.1% of the company’s shares are sold short. Based on an […]